Open AccessLEFLUNOMIDE AS A POTENTIAL SECOND-LINE DRUG IN THE TREATMENT OF SARCOIDOSIS
Author(s) -
А. А. Визель,
И. Ю. Визель
Publication year - 2019
Publication title -
tuberkulez i bolezni lëgkih/tuberkulëz i bolezni lëgkih
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.226
H-Index - 12
eISSN - 2542-1506
pISSN - 2075-1230
DOI - 10.21292/2075-1230-2019-97-8-52-58
Subject(s) - leflunomide , dihydroorotate dehydrogenase , sarcoidosis , rheumatoid arthritis , medicine , prodrug , methotrexate , drug , pyrimidine metabolism , purine , immunology , pharmacology , enzyme , biochemistry , biology